Mr David Hoover Morgan, MD | |
8371 Hwy 72 West, Suite 202, Madison, AL 35758-9505 | |
(256) 830-1776 | |
(256) 830-1719 |
Full Name | Mr David Hoover Morgan |
---|---|
Gender | Male |
Speciality | Urology |
Location | 8371 Hwy 72 West, Madison, Alabama |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841250693 | NPI | - | NPPES |
000027094 | Medicaid | AL | |
000027094 | Other | AL | BLUE CROSS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 18103 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr David Hoover Morgan, MD 8371 Hwy 72 West, Suite 202, Madison, AL 35758 Ph: (256) 830-1776 | Mr David Hoover Morgan, MD 8371 Hwy 72 West, Suite 202, Madison, AL 35758-9505 Ph: (256) 830-1776 |
News Archive
Cellular Biomedicine Group, Inc. today announced the interim results of its Phase I/IIa clinical trial for human adipose-derived mesenchymal precursor cell (haMPC) therapy for Knee Osteoarthritis, which tests the safety and efficacy of intra-articular injections of autologous (patient's own) haMPCs in order to reduce inflammation and repair damaged joint cartilage.
Individuals previously infected with the hepatitis B virus (HBV) who receive chemotherapy or immunosuppressive treatment may be at risk of reactivating the disease according to a summary of report from the Emerging Trends Conference, "Reactivation of Hepatitis B," and published in Hepatology, a journal of the American Association for the Study of Liver Diseases.
FDA has approved a porcine insulin zinc suspension product as the first drug for treating diabetic dogs. Prior to the development of this product, the only treatment veterinarians could use on diabetic dogs was human insulin, which is less compatible with a dog's metabolic system.
Female adolescent blood donors are more likely to have low iron stores and iron deficiency anemia than adult female blood donors and nondonors, which could have significant negative consequences on their developing brains, a new study led by Johns Hopkins researchers suggests.
› Verified 2 days ago